Products

THINQ
CorticoMetrics
Neurology AI
THINQ by CorticoMetrics is an FDA-cleared AI-based software for MRI brain volumetric reporting, providing quantitative measurements and visualizations of brain structures to assist radiologists and neurologists in assessing neurological conditions.

See all 1 product →

About CorticoMetrics

CorticoMetrics is a privately-held healthcare AI company that originated in 2012 as a spin-off from technology developed at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH). The company’s primary mission is to enhance clinical decision-making in neuroradiology by supplementing qualitative assessments with quantitative analysis of magnetic resonance imaging (MRI) scans of the brain. Their foundational technology is FreeSurfer, a comprehensive suite of automated neuroimaging tools for brain morphometry, initially developed at MGH for research, which CorticoMetrics is now translating into clinical applications.

CorticoMetrics’ flagship AI-based software, THINQ, received FDA 510(k) clearance in November 2020 for MRI brain volumetric reporting. THINQ automates the segmentation, labeling, and volumetric measurement of 30 critical brain structures from 3D T1-weighted MRI scans. It generates visual and quantitative reports that compare individual brain volumes against age and gender-matched reference percentile data, thereby assisting radiologists and neurologists in the assessment of various neurological conditions. These conditions include, but are not limited to, epilepsy, dementia, multiple sclerosis, traumatic brain injury, and hydrocephalus. Additionally, CorticoMetrics offers the “Brain Gauge,” a cognitive assessment tool that utilizes touch-based sensory testing to evaluate eight key components of brain health and provide a comprehensive mental fitness score, applicable in clinical, athletic, and home settings.

Focus Areas

Neuroimaging analysis MRI brain volumetric reporting quantitative analysis of MRI scans neurological disorders clinical decision support in neuroradiology dementia epilepsy multiple sclerosis traumatic brain injury hydrocephalus

Business Intelligence

Key InvestorsNIH SBIR/STTR grants
PartnershipsMassachusetts General Hospital (MGH), Innolitics
TechnologyFreeSurfer (foundation of software technology), AI-based software, Python (ported from MATLAB)
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Neuroimaging Analysis Expertise
CorticoMetrics specializes in advanced neuroimaging analysis, commercializing software like FreeSurfer and developing AI-based solutions for quantitative insights into neurological disorders.
Automated MRI Brain Volumetric Reporting
Their FDA 510(k) cleared software, THINQu2122, automatically segments T1-weighted MRI brain images, providing volumetric measurements and visualizations of 30 critical brain structures.
Quantitative Analysis & Clinical Decision Support
THINQu2122 delivers objective, quantitative neuromorphometry reports that compare brain volumes to age and gender-matched reference percentile data, significantly augmenting patient assessment for radiologists and neurologists.
Broad Neurological Disorder Coverage
The software aids in the assessment of a wide range of neurological conditions, including dementia, epilepsy, multiple sclerosis, traumatic brain injury, and hydrocephalus.
FDA Cleared Technology
THINQu2122 is an FDA 510(k) cleared medical device, ensuring regulatory compliance and reliability for clinical use in the United States.
Physician Tip

CorticoMetrics' THINQu2122 offers physicians objective and reproducible MRI brain volumetric data, which significantly enhances diagnostic confidence and supports precise clinical decision-making. The automated segmentation and reporting streamline workflow, increasing efficiency and examination throughput for radiologists and neurologists. Physicians can leverage the detailed, comparative reports to accurately assess a wide array of neurological disorders, monitor disease progression over time, and ultimately improve patient outcomes through data-driven insights. The FDA clearance further assures the reliability and clinical utility of their AI-based solution.

THINQu2122 is designed for deployment in a high-performance computing environment within a clinical workflow, suggesting robust integration capabilities with existing hospital IT infrastructure. The brain segmentations are also available in DICOM format as encapsulated JPEG images, facilitating compatibility with various Picture Archiving and Communication Systems (PACS) and other imaging platforms.

Products by CorticoMetrics

1 product in the directory

THINQ
CorticoMetrics
Neurology AI
THINQ by CorticoMetrics is an FDA-cleared AI-based software for MRI brain volumetric reporting, providing quantitative measurements and visualizations of brain structures to assist radiologists and neurologists in assessing neurological conditions.

Reviews & Opinions

No web reviews on file yet for CorticoMetrics. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about CorticoMetrics.

Loading videos...

Videos load interactively. If none appear, search YouTube for CorticoMetrics →

View all on YouTube

Press & Coverage

Medical Device Network
CorticoMetrics' neuroimaging software gets FDA 510(k) clearance
CorticoMetrics received FDA 510(k) clearance for its AI-based software, THINQ, for MRI brain volumetric reporting in November 2020. This software provides quantitative information to radiologists and neurologists for assessing various neurological disorders.
2020-11
PR Newswire
CorticoMetrics Announces FDA 510(k) Clearance of THINQu2122 for MRI Brain Volumetric Reporting
CorticoMetrics announced on November 24, 2020, that it received FDA 510(k) clearance for THINQu2122, its AI-based software designed to provide quantitative information from MRI brain scans to aid in the assessment of neurological conditions.
2020-11
National Institute on Aging - NIH
CorticoMetrics resubmitted full application - National Institute on Aging - NIH
In June 2019, CorticoMetrics resubmitted an application to the NIH, detailing its efforts to commercialize neuroimaging analysis software and its first product, THINQ, which generates neuromorphometry reports from MRI data. The company had secured approximately $5 million in NIH funding to date.
2019-06
PMC (PubMed Central)
Cortical Engagement Metrics During Reactive Balance Are Associated With Distinct Aspects of Balance Behavior in Older Adults - PMC
This peer-reviewed article from 2021 investigates the relationship between cortical engagement metrics during reactive balance and balance behavior in older adults. It highlights increased reliance on the cerebral cortex for postural stability with aging.
2021-07
PMC (PubMed Central)
Longitudinal stability of cortical grey matter measures varies across brain regions, imaging metrics, and testing sites in the ABCD study - PMC
Published in 2024, this peer-reviewed study examines the longitudinal stability of cortical grey matter measures, noting variations across brain regions, imaging metrics, and testing sites in the ABCD study.
2024-01
PMC (PubMed Central)
Reduced Cortical Thickness Correlates of Cognitive Dysfunction in Post-COVID-19 Condition: Insights from a Long-Term Follow-up - PMC
This 2024 peer-reviewed article explores reduced cortical thickness as a correlate of cognitive dysfunction in post-COVID-19 condition, offering insights from a long-term follow-up study.
2024-01
PR Newswire
Corti steps up its support for the next wave of healthcare startups as OpenAI pushes into the space and others retreat from Europe - PR Newswire
Corti, a company focused on clinical-grade AI, announced in May 2026 a Startup Acceleration Program to support healthcare AI builders, amidst tightening regulations and the entry of major tech players like OpenAI into the healthcare AI space.
2026-05
PR Newswire
Cortechs.ai Collaborates with Microsoft to Bring AI-Powered Imaging Insights Directly into Radiology Workflows - PR Newswire
Cortechs.ai announced a collaboration with Microsoft in June 2026 to integrate its AI-powered imaging insights, including NeuroQuantu00ae and OnQu2122 Prostate, directly into radiology workflows via Microsoft Azure.
2026-06

Frequently Asked Questions

CorticoMetrics' primary product is THINQu2122, an AI-based software designed for MRI brain volumetric reporting. It automatically segments T1-weighted MRI brain images, providing volumetric measurements and visualizations of 30 critical brain structures. These measurements are then compared to age and gender-matched reference percentile data to aid in quantitative analysis of MRI scans.
THINQu2122 augments qualitative assessment with quantitative analysis of MRI scans, aiming to improve the accuracy and sensitivity of information available to radiologists and neurologists. By providing objective volumetric data and comparisons, it aids in the detection and diagnosis of various neurological conditions, thereby enhancing clinical decision support and patient outcomes.
CorticoMetrics' THINQu2122 software is designed to assist in the assessment of a broad spectrum of neurological disorders and conditions. These include dementia, epilepsy, multiple sclerosis, traumatic brain injury, and hydrocephalus.
CorticoMetrics has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its THINQu2122 AI-based software. The company's development processes are also compliant with IEC 62304 and FDA 21 CFR 820 standards, ensuring high quality and safety for medical devices.
CorticoMetrics integrates its technology by commercializing neuroimaging analysis software, like THINQu2122, which is based on the widely recognized FreeSurfer. They have established partnerships, including a distribution deal with EnvoyAI (now part of TeraRecon), to integrate THINQu2122 into broader imaging platforms and workflows.
Specific pricing models for THINQu2122 are not publicly detailed in the provided information. Institutions interested in acquiring THINQu2122 for their clinical practice should contact CorticoMetrics directly or inquire through their distribution partners, such as TeraRecon.
While detailed support channels for THINQu2122 are not extensively outlined, CorticoMetrics provides contact information for inquiries, suggesting direct support for their product. Given their partnerships and focus on clinical integration, support would likely be facilitated through direct communication with the company or their distribution network.
CorticoMetrics, founded in 2012, is a privately held company with a team experienced in neuroimaging and computing technology. They have secured substantial NIH funding for research and development, indicating ongoing investment and a stable foundation in the medical technology sector.

Related Companies

Visiopharm is a leading provider of AI-driven precision pathology software, catering to both research and diagnostic applications. For physicians, Visiopharm offers advanced tools that transform pathology through image analysis, aiming to enhance precision and productivity in pathology labs. The company has developed nine diagnostic algorithms cleared under IVDR for EU and UK customers, which provide […]

TSI (Transworld Systems Inc.) is a long-standing company primarily known for its debt collection and business process outsourcing services. While they serve various industries, including healthcare, their core offering is focused on accounts receivable management and collections rather than healthcare-specific AI development. They provide solutions to help healthcare providers manage patient accounts, improve cash flow, […]

TrialX is a healthcare AI company specializing in clinical research and space health informatics. The company develops platforms designed to connect patients with clinical trials and facilitate research data collection. Their offerings include an enterprise patient recruitment platform (iConnect) that provides a clinical trials finder (Dory), study website builders, pre-screeners, referral tracking, and volunteer registries. […]

Thinkitive is a global IT services and solutions company that specializes in digital transformation, enterprise application services, outsourced product development, and a testing center of excellence. For physicians, Thinkitive offers a range of AI-driven healthcare solutions designed to streamline clinical and administrative workflows, enhance patient care, and improve operational efficiency. Their services include custom healthcare […]

Taction Software is a U.S.-based healthcare IT and custom software development company specializing in HIPAA-compliant solutions. They build AI-powered applications for healthcare, ranging from rapid clinical AI prototypes to production-grade systems with EHR integration, ambient documentation, and predictive analytics. The company focuses on transforming healthcare delivery through secure, compliant, and innovative software solutions that aim […]

SUPERWISE offers an enterprise AI governance and operations platform designed to help organizations, including those in healthcare, deploy and manage autonomous AI systems with oversight and control. The platform addresses governance, compliance, and operational challenges associated with AI and machine learning deployments. It features real-time guardrails for AI systems, model observability capabilities, and compliance automation, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.